It has come to the Publisher’s attention that the above published retrospective review article was missing an ethics statement stating consent was waived.
The following statement has been supplied by the author:
This work was part of a larger study subject to review and approval had been received by Belfast Health & Social Care Trust Research Governance and the Office of Research Ethics Committee’s NI (ORECNI).
Both the Authors and Publisher would like to apologise for the oversight.
Article info
Identification
Copyright
Crown Copyright © 2019 Published by Elsevier B.V. on behalf of European Society for Radiotherapy & Oncology.
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy
ScienceDirect
Access this article on ScienceDirectLinked Article
- Observed high incidence of prostatic calculi with the potential to act as natural fiducials for prostate image guided radiotherapyTechnical Innovations and Patient Support in Radiation Oncology Vol. 9
- PreviewProstate cancer (PCa) is the most common cancer in men in the UK and approximately half of patients diagnosed will receive radiotherapy alone or in conjunction with surgery or hormone therapy as part of their disease management [1]. Despite the rapid evolution of imaged guided radiotherapy (IGRT), verification of soft tissue targets like the prostate gland, remains challenging and image analysis is prone to uncertainty and inter-observer variability [2,3]. IGRT for PCa frequently employs surgically implanted fiducial markers (FMs) as an aid to target verification.
- Full-Text
- Preview
